Effects of different doses of dexmedetomidine on heart rate and blood pressure in intensive care unit patients

Zhang,Xiaoyan; Wang,Ruilan; Lu,Jian; Jin,Wei; Qian,Yongbin; Huang,Peijie; Tian,Rui; Li,Yan

doi:10.3892/etm.2015.2872

Effects of different doses of dexmedetomidine on heart rate and blood pressure in intensive care unit patients

Authors:
- Xiaoyan Zhang
- Ruilan Wang
- Jian Lu
- Wei Jin
- Yongbin Qian
- Peijie Huang
- Rui Tian
- Yan Li
View Affiliations

Affiliations: Department of Emergency, First People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200080, P.R. China
Published online on: November 17, 2015 https://doi.org/10.3892/etm.2015.2872
Pages: 360-366

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to observe and compare the sedative effect of different doses of DEX on heart rate (HR) and blood pressure (BP) in critically ill patients admitted to intensive care units (ICUs). The study included patients that were retained in ICUs and required sedation between January and March 2014. Patients were excluded if they had a BP of >200 mmHg, a HR of <60 bpm or were in a state of shock. The included patients were randomized into three groups: Group A, 1.0 µg/kg/10 min DEX; group B, 0.5 µg/kg/10 min DEX; and group C, 0.4 µg/kg/h DEX. After receiving these initial designated doses of DEX via an intravenous (IV) infusion pump for 10 min, the patients were maintained continuously at an identical dose of 0.4 µg/kg/h DEX. Ramsay score, HR, systolic blood pressure (SBP), diastolic blood pressure (DBP), breathing rate (BR) and peripheral capillary oxygen saturation (SpO2) were recorded prior to the IV pump infusion and at 2, 4, 6, 8, 10, 60, 120, 180 and 240 min following infusion. Patients in groups A and B achieved sedation more rapidly compared with those in group C (P<0.05). HR decreased more significantly at 8 and 60 min after the initial IV pump infusion with DEX in groups A and B compared with group C (P<0.05). SBP decreased significantly at 10 min after IV pump infusion in group A compared with groups B and C (P<0.05). No significant difference existed in the SBP reduction trend between the three groups during the maintenance period. Therefore, the routine dose of DEX (0.4 µg/kg/h) provides an ideal sedative effect in ICU patients. The recommended loading dose for a more rapid sedation is 0.5 µg/kg/h. High loading doses of DEX via IV pump infusion should be avoided in elderly individuals, patients with acute exacerbation of chronic obstructive pulmonary disease and anemic patients, in whom combination medication, such as midazolam or propofol, may be considered when necessary.

View Figures

View References

1	Oldham M and Pisani MA: Sedation in critically ill patients. Crit Care Clin. 31:563–87. 2015. View Article : Google Scholar : PubMed/NCBI
2	Genta PR, Eckert DJ, Gregorio MG, Danzi NJ, Moriya HT, Malhotra A and Lorenzi-Filho G: Critical closing pressure during midazolam-induced sleep. J Appl Physiol (1985). 111:1315–1322. 2011. View Article : Google Scholar : PubMed/NCBI
3	Perrier ND, Baerga-Varela Y and Murray MJ: Death related to propofol use in an adult patient. Crit Care Med. 28:3071–3074. 2000. View Article : Google Scholar : PubMed/NCBI
4	Pichot C, Ghignone M and Quintin L: Dexmedetomidine and clonidine: From second- to first-line sedative agents in the critical care setting? J Intensive Care Med. 27:219–237. 2012. View Article : Google Scholar : PubMed/NCBI
5	Rayner SG, Weinert CR, Peng H, Jepsen S and Broccard AF: Study Institution: Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Intensive Care. 23:122012. View Article : Google Scholar
6	Yang L, Xu JM, Jiang X, Ruan W, Cui Y and He L: Effect of dexmedetomidine on plasma brain-derived neurotrophic factor: A double-blind, randomized and placebo-controlled study. Ups J Med Sci. 118:235–239. 2013. View Article : Google Scholar : PubMed/NCBI
7	Chrysostomou CI, Beerman L, Shiderly D, Berry D, Morell VO and Munoz R: Dexmedetomidine: A novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: A preliminary study. Anesth Analg. 107:1514–1522. 2008. View Article : Google Scholar : PubMed/NCBI
8	Jalowiecki P, Rudner R, Gonciarz M, Kawecki P, Petelenz M and Dziurdzik P: Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy. Anesthesiology. 103:269–273. 2005. View Article : Google Scholar : PubMed/NCBI
9	Giovannitti JA Jr, Thoms SM and Crawford JJ: Alpha-2 adrenergic receptor agonists: A review of current clinical applications. Anesth Prog. 62:31–39. 2015. View Article : Google Scholar : PubMed/NCBI
10	Longrois D, Conti G, Mantz J, Faltlhauser A, Aantaa R and Tonner P: Sedation in non-invasive ventilation: Do we know what to do (and why)? Multidiscip Respir Med. 9:562014. View Article : Google Scholar : PubMed/NCBI
11	Nishizawa T, Suzuki H, Sagara S, Kanai T and Yahagi N: Dexmedetomidine versus midazolam for gastrointestinal endoscopy: A meta-analysis. Dig Endosc. 27:8–15. 2015. View Article : Google Scholar : PubMed/NCBI
12	Goodwin HE, Gill RS, Murakami PN, Thompson CB, Lewin JJ 3rd and Mirski MA: Dexmedetomidine preserves attention/calculation when used for cooperative and short-term intensive care unit sedation. J Crit Care. 28:1113.e7–1113.e10. 2013. View Article : Google Scholar
13	Ludtke KA, Stanley KS, Yount NL and Gerkin RD: Retrospective review of critically ill patients experiencing alcohol withdrawal: Dexmedetomidine versus propofol and/or lorazepam continuous infusions. Hosp Pharm. 50:208–213. 2015. View Article : Google Scholar : PubMed/NCBI
14	Bhana N, Goa KL and McClellan KJ: Dexmedetomidine. Drugs. 59:263–270. 2000. View Article : Google Scholar : PubMed/NCBI
15	Bassett R, Adams KM, Danesh V, Groat PM, Haugen A, Kiewel A, Small C, Van-Leuven M, Venus S and Ely EW: Rethinking critical care: Decreasing sedation, increasing delirium monitoring, and increasing patient mobility. Jt Comm J Qual Patient Saf. 41:62–74. 2015.PubMed/NCBI
16	Del Bufalo C, Morelli A, Bassein L, Fasano L, Quarta CC, Pacilli AM and Gunella G: Severity scores in respiratory intensive care: APACHE II predicted mortality better than SAPS II. Respir Care. 40:1042–1047. 1995.PubMed/NCBI
17	Maraboto E: ABCDEs of ICU: Choice of sedative. Crit Care Nurs Q. 36:157–162. 2013. View Article : Google Scholar : PubMed/NCBI
18	Devabhakthuni S, Armahizer MJ, Dasta JF and Kane-Gill SL: Analgosedation: A paradigm shift in intensive care unit sedation practice. Ann Pharmacother. 46:530–540. 2012. View Article : Google Scholar : PubMed/NCBI
19	Gudmundsson G, Ulrik CS, Gislason T, Lindberg E, Brøndum E, Bakke P and Janson C: Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: A prospective observational study in the Nordic countries. Int J Chron Obstruct Pulmon Dis. 7:571–576. 2012.PubMed/NCBI
20	Ai-Ping C, Lee KH and Lim TK: In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: A retrospective study. Chest. 128:518–524. 2005. View Article : Google Scholar : PubMed/NCBI
21	Andreas S, Haarmann H, Klarner S, Hasenfuss G and Raupach T: Increased sympathetic nerve activity in COPD is associated with morbidity and mortality. Lung. 192:235–241. 2014. View Article : Google Scholar : PubMed/NCBI
22	Gerlach AT and Dasta JF: Dexmedetomidine: An updated review. Ann Pharmacother. 41:245–252. 2007. View Article : Google Scholar : PubMed/NCBI
23	Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW and Rocha MG: SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group: Dexmedetomidine vs. midazolam for sedation of critically ill patients: A randomized trial. JAMA. 301:489–499. 2009. View Article : Google Scholar : PubMed/NCBI
24	Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, et al: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA. 298:2644–2653. 2007. View Article : Google Scholar : PubMed/NCBI
25	Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C and Reitz BA: Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 50:206–217. 2009. View Article : Google Scholar : PubMed/NCBI
26	Ozaki M, Takeda J, Tanaka K, Shiokawa Y, Nishi S, Matsuda K, Doi M, Kakihana Y, Fujino Y, Takinami M and Kawai M: Safety and efficacy of dexmedetomidine for long-term sedation in critically ill patients. J Anesth. 28:38–50. 2014. View Article : Google Scholar : PubMed/NCBI
27	Takata K, Adachi YU, Suzuki K, Obata Y, Sato S and Nishiwaki K: Dexmedetomidine-induced atrioventricular block followed by cardiac arrest during atrial pacing: A case report and review of the literature. J Anesth. 28:116–120. 2014. View Article : Google Scholar : PubMed/NCBI
28	Bharati S, Pal A, Biswas C and Biswas R: Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: A case series and review of published case reports. Acta Anaesthesiol Taiwan. 49:165–167. 2011. View Article : Google Scholar : PubMed/NCBI
29	Sakamaki F, Satoh T, Nagaya N, Kyotani S, Nakanishi N and Ishida Y: Abnormality of left ventricular sympathetic nervous function assessed by (123) I-metaiodobenzylguanidine imaging in patients with COPD. Chest. 116:1575–1581. 1999. View Article : Google Scholar : PubMed/NCBI
30	Victor RG and Shafiq MM: Sympathetic neural mechanisms in human hypertension. Curr Hypertens Rep. 10:241–247. 2008. View Article : Google Scholar : PubMed/NCBI
31	Brown SJ, Raman A, Barnes MJ and Mundel T: Autonomic cardiovascular response to acute hypoxia and passive head-up tilting in humans. Eur J Appl Physiol. 113:1731–1736. 2013. View Article : Google Scholar : PubMed/NCBI
32	Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G and Peres-Bota D: ABC (Anemia and Blood Transfusion in Critical Care) Investigators: Anemia and blood transfusion in critically ill patients. JAMA. 288:1499–1507. 2002. View Article : Google Scholar : PubMed/NCBI
33	Dünser MW and Hasibeder WR: Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress. J Intensive Care Med. 24:293–316. 2009. View Article : Google Scholar : PubMed/NCBI
34	Franchitto N, Despas F, Labrunée M, Roncalli J, Boveda S, Galinier M, Senard JM and Pathak A: Tonic chemoreflex activation contributes to increased sympathetic nerve activity in heart failure-related anemia. Hypertension. 55:1012–1017. 2010. View Article : Google Scholar : PubMed/NCBI